1. Surgical treatment of metachronous second primary lung cancer after complete resection of non–small cell lung cancer 
Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D. Cassivi, MD, Claude Deschamps, MD, Francis C. Nichols, MD, Dennis A. Wigle, MD, PhD, K. Robert Shen, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 145, Issue 3, Pages (March 2013)
DOI: /j.jtcvs
Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
Kaplan-Meier estimates of survival after resection of a second metachronous second primary lung cancer (MSPLC) based on tumor size (P = .003). NSCLC, Non–small cell lung cancer.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

3. Figure 2
Kaplan-Meier estimates of survival after a second metachronous second primary lung cancer (MSPLC) based on histology, sex, modality of surveillance, lymph node status, extent of resection, disease-free interval (DFI), and adenocarcinoma versus squamous cell histology (P = .09). NSCLC, Non–small cell lung cancer; CT, computed tomography; CXR, chest radiograph.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions